TikTok Content Creators Fueling Parallel Trade for Unlicensed Slimming Medication

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer laws, risking penalties, legal action or prison.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down violative material and banned associated keywords and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for mixing or injecting at home.

After minutes of entering one community, a seller posted WhatsApp details, where most transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, messages show black plastic parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly serious medical dangers”.

Jasmine Green
Jasmine Green

A digital strategist with over a decade of experience in helping brands scale through innovative marketing techniques.